Search

Hutchison China MediTech Ltd ADR

Aperta

SettoreSettore sanitario

13.78 -0.86

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

13.55

Massimo

13.87

Metriche Chiave

By Trading Economics

Entrata

-8.9M

-8M

Vendite

3.7M

139M

P/E

Media del settore

144.8

55.725

Margine di Profitto

-5.724

Dipendenti

1,790

EBITDA

18M

4M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+21.1% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

605M

2.5B

Apertura precedente

14.64

Chiusura precedente

13.78

Notizie sul Sentiment di mercato

By Acuity

50%

50%

118 / 339 Classifica in Healthcare

Hutchison China MediTech Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 set 2026, 23:56 UTC

News

EUR/GBP rises as Germany's business expectations for September exceed forecasts, reaching 90.4 and indicating notable strength in today's performance.

24 set 2026, 23:55 UTC

News

LPL Financial reported total client assets of $2.60 trillion for August 2026, with the stock trading modestly lower in after-market hours.

24 set 2026, 23:55 UTC

News
Social Media

MGM Resorts International shares are modestly lower in after-market trading as it considers a bid for People Incorporated amid uncertain negotiations.

24 set 2026, 23:50 UTC

News

Regenxbio Inc. shares rose in after-market trading following positive three-year data for suragene lomparvovec, showing significant improvement in diabetic retinopathy patients.

24 set 2026, 23:46 UTC

News

Pentair PLC shares are trading lower in after-market hours amid a securities class action lawsuit alleging false statements about inventory issues affecting sales.

24 set 2026, 23:45 UTC

News

Global Payments Inc. is trading roughly flat in after-market hours, positioned below its 20-day moving average amid the Fed's announcement on cross-border transaction support.

24 set 2026, 23:45 UTC

News

EUR/NOK is trading higher as Germany's business expectations for September exceeded forecasts at 90.4, compared to the previous 89.

24 set 2026, 23:31 UTC

News

Celanese Corporation shares declined in after-market hours following the announcement of price increases for UHMW-PE and POM products, effective October 8, 2026.

24 set 2026, 23:30 UTC

Event
News

Merck & Co Inc's stock traded modestly lower in after-market hours following the announcement of Phase 2b/3 BRUNELLO trial results for diabetic macular edema.

24 set 2026, 23:21 UTC

News

CrowdStrike is collaborating with Snowflake to integrate its AI-native Falcon platform into the Snowflake Marketplace, with shares modestly higher in after-market trading.

24 set 2026, 23:16 UTC

Correlated Moves
News

Rockwell Automation shares traded lower in after-market hours following the announcement of Chief Revenue Officer Scott A. Genereux's retirement and Wells Fargo's Equal Weight rating.

24 set 2026, 23:16 UTC

News

EUR/JPY traded higher as Germany's September business expectations exceeded forecasts at 90.4, up from 89.3, contributing to modest gains in the currency pair.

24 set 2026, 23:06 UTC

News

General Electric Co has secured a $199.7 million contract for the R-391 Propeller Assembly, with shares modestly higher in after-market trading.

24 set 2026, 23:06 UTC

News

Wells Fargo analyst Joseph O'Dea initiated coverage on Otis Worldwide Corp with an Underweight rating, as shares traded roughly flat after market hours.

24 set 2026, 23:06 UTC

Social Media
News

GameStop's shares are trading lower in after-market hours despite CEO Ryan Cohen's reported share purchases, influenced by a broader market decline.

24 set 2026, 23:06 UTC

News
Event

Jabil Inc. shares are higher in after-market trading following a $1.7 billion contract manufacturing agreement with Akamai Technologies.

24 set 2026, 23:06 UTC

News

Delta Air Lines declared a quarterly dividend of $0.2150 per share, while its shares are declining in after-market trading amid broader market trends.

24 set 2026, 23:06 UTC

Social Media
News

Raises quarterly dividend to $1.17 per share

24 set 2026, 23:06 UTC

News

EUR/NZD is trading slightly higher as Germany's business expectations for September exceeded forecasts, coming in at 90.4, above the previous reading of 89.

24 set 2026, 23:06 UTC

Macro Event
News

The USD/NOK exchange rate is modestly higher, supported by lower U.S. initial jobless claims, reflecting recent macroeconomic developments.

24 set 2026, 23:06 UTC

Correlated Moves
News

U.S. natural gas storage levels reached 53 billion cubic feet, surpassing forecasts, while USD/ZAR trades modestly higher amid correlated movements with USD/MXN.

24 set 2026, 23:06 UTC

News

Newmont Corporation shares were roughly flat in after-market trading ahead of its Q3 2026 results announcement on October 22, 2026.

24 set 2026, 23:05 UTC

News

Vertiv Holdings Co shares rose in after-market hours after Wells Fargo initiated coverage with an Overweight rating and a $340.00 price target.

24 set 2026, 23:05 UTC

News

Automatic Data Processing Inc. is moving lower in after-market trading following the nomination of David W. Kenny and Nancy McKinstry to its Board of Directors.

24 set 2026, 23:05 UTC

News

Northrop Grumman Corp is trading roughly flat in after-market hours as the U.S. Air Force seeks input for replacing outdated radar systems.

24 set 2026, 23:01 UTC

News

nVent Electric PLC traded modestly lower in after-market hours following Wells Fargo's Equal Weight rating and $182.00 price target initiation by analyst Stephen Tusa.

24 set 2026, 23:01 UTC

News

AeroVironment Inc is declining in after-market trading despite securing a $464.8 million U.S. Army contract for its Enduring High Energy Laser program.

24 set 2026, 23:01 UTC

Social Media
News
Event

Costco reported fourth-quarter fiscal 2026 net sales of $93.9 billion and net income of $3.0 billion, exceeding expectations, with a slight increase in after-market trading.

24 set 2026, 23:01 UTC

News
Event

Scholastic Corp reported a fiscal Q1 net loss of $71.2 million and revenues of $216.8 million, prompting a sharp decline in shares after-market hours.

24 set 2026, 23:01 UTC

News

Starbucks plans to close about 250 locations, incurring $300 million in charges, while shares are modestly higher in after-market trading.

Confronto tra pari

Modifica del prezzo

Hutchison China MediTech Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

21.1% in crescita

Previsioni per 12 mesi

Media 16.833 USD  21.1%

Alto 18.5 USD

Basso 14 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Hutchison China MediTech Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

118 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.